NovoCure NVCR France — Net revenues
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by NovoCure in its filing.
Tagged under the XBRL concept us-gaap:Revenues.
The official record: NovoCure’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about NovoCure's france — net revenues.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is NovoCure's france — net revenues?
- NovoCure (NVCR) reported france — net revenues of $22.88M in Q1 2026.
- How has NovoCure's france — net revenues changed year-over-year?
- NovoCure's france — net revenues increased by 28.1% year-over-year, from $17.86M to $22.88M.
- What does france — net revenues mean?
- This metric represents the total gross sales generated from the commercialization of medical devices and therapeutic solutions within the French geographic market, net of any applicable returns, allowances, or discounts. It serves as a key indicator of the company's market penetration and adoption rates for its oncology treatment technologies in this specific region. Tracking this revenue stream allows investors to assess the growth trajectory and commercial success of the company's international expansion efforts.